Pam Brick

A study of sarcoidosis assessed the extent to which increasing BMI and obstructive sleep apnea were associated with disease development.

In patients with long COVID who were not hospitalized for COVID-19, can hyperpolarized 129Xenon MRI offer useful information on potential lung abnormalities?

Final evidence from the WHO Solidarity clinical trials shows that remdesivir has only a slight protective effect and only among certain patients with COVID-19.

Investigators analyzed the safety and efficacy of hyperimmune intravenous immunoglobulin with standard of care for patients hospitalized with COVID-19.

Can individuals who are antibody deficient produce SARS-CoV-2-specific CD4+ and CD8+ T cell responses to vaccination or infection?

Are clinical guidelines developed during the pandemic for COVID-19 inpatient drug therapies “trustworthy” by National Academy of Medicine standards?

Are patients with fibrotic interstitial lung disease at risk of malignancy when treated with the immunomodulatory drugs MMF and AZA?